Atom Investors LP Omeros Corp Transaction History

Atom Investors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$9.57 - $21.32 $3.26 Million - $7.26 Million	-340,389 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.21 - $16.99 $505,298 - $703,114	41,384 Added 13.84%	340,389 $5.01 Million
Q1 2020 May 15, 2020	BUY	$9.03 - $19.72 $770,394 - $1.68 Million	85,315 Added 39.92%	299,005 $4 Million
Q4 2019 Feb 13, 2020	BUY	$13.01 - $17.15 $266,874 - $351,797	20,513 Added 10.62%	213,690 $3.01 Million
Q3 2019 Nov 14, 2019	BUY	$14.55 - $20.56 $904,282 - $1.28 Million	62,150 Added 47.43%	193,177 $3.16 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.62 $1.97 Million - $2.57 Million	131,027 New	131,027 $2.06 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $762M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.